- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 796
Cruise crushes $1.15bn fundraise
GM's autonomous driving spinoff, Cruise Automation, has received $1.15bn from investors including SoftBank Vision Fund and Honda as well as its parent company.
May 8, 2019SamanTree branches out with $9.3m
Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.
May 8, 2019Rfrnz reaches seven-digit understanding
TUM automated legal analysis spinout Rfrnz has secured backing from Unternehmertum-operated Initiative for Industrial Innovations, HTGF and unnamed additional investors.
May 8, 2019Dynabind dines on seed financing
TU Dresden-founded drug discovery platform operator Dynabind has advanced research from the lab of Yixin Zhang in the university’s B Cube Center for Molecular Bioengineering.
May 8, 2019Byton moves closer to $500m series C
FAW Group will reportedly provide $100m for Byton for a $500m round likely to value the electric SUV developer at more than $2.5bn.
May 8, 2019Gett gains $200m at $1.5bn valuation
All Gett’s existing investors, including Volkswagen and Access Industries, have participated in a $120m extension that brought its latest round to $200m.
May 8, 2019SoftBank helps Clip collect $100m
SoftBank tapped its Innovation Fund to invest about $20m in the card reader developer as part of a $100m round that valued it at up to $400m.
May 8, 2019Noom finds room for $58m
Existing backer Samsung Ventures contributed to a round that boosted the health maintenance platform developer's overall funding to more than $86m.
May 8, 2019Ola Electric Mobility extends series A round
Ola's electric vehicle-focused spinoff has added an undisclosed amount to the $56m in series A funding the company received in March.
May 8, 2019Confo confirms $33.4m
The funding, provided by investors including Qbic, will allow VUB and VIB spinout Confo Therapeutics to accelerate its drug discovery efforts and move towards clinical trials.
May 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


